KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressConvertible DebtCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Exact Sciences (EXAS) Cash & Current Investments: 2009-2025

Historic Cash & Current Investments for Exact Sciences (EXAS) over the last 17 years, with Sep 2025 value amounting to $1.0 billion.

  • Exact Sciences' Cash & Current Investments fell 1.77% to $1.0 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $3.7 billion, marking a year-over-year increase of 8.48%. This contributed to the annual value of $1.0 billion for FY2024, which is 33.48% up from last year.
  • Exact Sciences' Cash & Current Investments amounted to $1.0 billion in Q3 2025, which was up 16.85% from $858.4 million recorded in Q2 2025.
  • Exact Sciences' 5-year Cash & Current Investments high stood at $1.4 billion for Q1 2021, and its period low was $632.1 million during Q4 2022.
  • Over the past 3 years, Exact Sciences' median Cash & Current Investments value was $786.2 million (recorded in 2025), while the average stood at $844.7 million.
  • Its Cash & Current Investments has fluctuated over the past 5 years, first tumbled by 45.09% in 2022, then surged by 39.04% in 2024.
  • Quarterly analysis of 5 years shows Exact Sciences' Cash & Current Investments stood at $1.0 billion in 2021, then slumped by 38.66% to $632.1 million in 2022, then increased by 23.03% to $777.6 million in 2023, then soared by 33.48% to $1.0 billion in 2024, then fell by 1.77% to $1.0 billion in 2025.
  • Its last three reported values are $1.0 billion in Q3 2025, $858.4 million for Q2 2025, and $786.2 million during Q1 2025.